Authors:
Takahashi, H
Takahashi, A
Maki, M
Sasai, H
Kamada, M
Citation: H. Takahashi et al., Effect of CETP on the plasma lipoprotein profile in four strains of transgenic mouse, BIOC BIOP R, 283(1), 2001, pp. 118-123
Citation: Ma. Arai et al., A new asymmetric Wacker-type cyclization and tandem cyclization promoted by Pd(II)-spiro bis(isoxazoline) catalyst, J AM CHEM S, 123(12), 2001, pp. 2907-2908
Citation: T. Minowa et al., Proteomic analysis of the small intestine and colon epithelia of adenomatous polyposis coli gene-mutant mice by two-dimensional gel electrophoresis, ELECTROPHOR, 21(9), 2000, pp. 1782-1786
Citation: H. Sasai et al., Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta 474) by a novel COX-2 inhibitor, JTE-522, CARCINOGENE, 21(5), 2000, pp. 953-958
Authors:
Schlemminger, I
Saida, Y
Groger, H
Maison, W
Durot, N
Sasai, H
Shibasaki, M
Martens, J
Citation: I. Schlemminger et al., Concept of improved rigidity: How to make enantioselective hydrophosphonylation of cyclic imines catalyzed by chiral heterobimetallic lanthanoid complexes almost perfect, J ORG CHEM, 65(16), 2000, pp. 4818-4825
Citation: Ma. Arai et al., Design and synthesis of the first spiro bis(isoxazoline) derivatives as asymmetric ligands, ORG LETT, 1(11), 1999, pp. 1795-1797
Authors:
Kushi, A
Sasai, H
Koizumi, H
Takeda, N
Yokoyama, M
Nakamura, M
Citation: A. Kushi et al., Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice, P NAS US, 95(26), 1998, pp. 15659-15664